These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9497860)

  • 1. Gaucher's disease: the best laid schemes of mice and men.
    Sidransky E; Ginns EI
    Baillieres Clin Haematol; 1997 Dec; 10(4):725-37. PubMed ID: 9497860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
    Tybulewicz VL; Tremblay ML; LaMarca ME; Willemsen R; Stubblefield BK; Winfield S; Zablocka B; Sidransky E; Martin BM; Huang SP
    Nature; 1992 Jun; 357(6377):407-10. PubMed ID: 1594045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher's disease: a review for the internist and hepatologist.
    Niederau C; Häussinger D
    Hepatogastroenterology; 2000; 47(34):984-97. PubMed ID: 11020862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher's disease: clinical features and natural history.
    Cox TM; Schofield JP
    Baillieres Clin Haematol; 1997 Dec; 10(4):657-89. PubMed ID: 9497857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
    Tayebi N; Reissner KJ; Lau EK; Stubblefield BK; Klineburgess AC; Martin BM; Sidransky E
    Pediatr Res; 1998 May; 43(5):571-8. PubMed ID: 9585001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher's disease in the presence of normal glucocerebrosidase activity.
    Schofield DE; Scott CR; Lage JM; Farrell DF
    Hum Pathol; 1992 May; 23(5):588-92. PubMed ID: 1568755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
    Tsuji S; Choudary PV; Martin BM; Stubblefield BK; Mayor JA; Barranger JA; Ginns EI
    N Engl J Med; 1987 Mar; 316(10):570-5. PubMed ID: 2880291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and ultrastructural features of Gaucher's cells--five case reports.
    Bogoeva B; Petrusevska G
    Acta Med Croatica; 2001; 55(3):131-4. PubMed ID: 11852732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.
    Starzl TE; Demetris AJ; Trucco M; Ricordi C; Ildstad S; Terasaki PI; Murase N; Kendall RS; Kocova M; Rudert WA
    N Engl J Med; 1993 Mar; 328(11):745-9. PubMed ID: 8437594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of the pro-inflammatory master regulator miR-155 does not mitigate neuroinflammation or neurodegeneration in a vertebrate model of Gaucher's disease.
    Watson L; Keatinge M; Gegg M; Bai Q; Sandulescu MC; Vardi A; Futerman AH; Schapira AHV; Burton EA; Bandmann O
    Neurobiol Dis; 2019 Jul; 127():563-569. PubMed ID: 30981829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Gaucher's cells in Hodgkin's disease.
    Lee KS; Tobin MS; Chen KT; Ahmed F; Gomez-Leon G
    Am J Med; 1982 Aug; 73(2):290-4. PubMed ID: 7114083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
    Vitner EB; Farfel-Becker T; Eilam R; Biton I; Futerman AH
    Brain; 2012 Jun; 135(Pt 6):1724-35. PubMed ID: 22566609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen.
    Willemsen R; van Dongen JM; Aerts JM; Schram AW; Tager JM; Goudsmit R; Reuser AJ
    Ultrastruct Pathol; 1988; 12(5):471-8. PubMed ID: 3194992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of nonneurologic Gaucher's disease that biochemically resembles the neurologic types.
    Glew RH; Gopalan V; Hubbell CA; Beutler E; Geil JD; Lee RE
    J Neuropathol Exp Neurol; 1991 Mar; 50(2):108-17. PubMed ID: 1672707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry.
    Willemsen R; van Dongen JM; Ginns EI; Sips HJ; Schram AW; Tager JM; Barranger JA; Reuser AJ
    J Neurol; 1987 Jan; 234(1):44-51. PubMed ID: 3819786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraosseous manifestation of Gaucher's disease type I: MR and histological appearance.
    Poll LW; Koch JA; vom Dahl S; Loxtermann E; Sarbia M; Niederau C; Häussinger D; Mödder U
    Eur Radiol; 2000; 10(10):1660-3. PubMed ID: 11044944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.